MLchartDataset catalogue

troxacitabine

Term · Oncology and biomedicine · MLC-T-ONC-008926

  1. A drug being studied for use as an anticancer agent.

  2. A dioxolane derivative and a novel L-configuration deoxycytidine analogue with potent antineoplastic activity. When incorporated into growing chain during DNA replication, troxacitabine stops DNA polymerization due to its unnatural L-configuration, in contrast to the normal nucleotides with D-configuration. As a result, this agent terminates DNA synthesis upon incorporated into DNA molecules, and consequently interrupts tumor cell proliferation.

Table 1. Record
IdentifierMLC-T-ONC-008926
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-008926",
  "term": "troxacitabine",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A drug being studied for use as an anticancer agent.",
    "A dioxolane derivative and a novel L-configuration deoxycytidine analogue with potent antineoplastic activity. When incorporated into growing chain during DNA replication, troxacitabine stops DNA polymerization due to its unnatural L-configuration, in contrast to the normal nucleotides with D-configuration. As a result, this agent terminates DNA synthesis upon incorporated into DNA molecules, and consequently interrupts tumor cell proliferation."
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/troxacitabine/"
}

Record 16,767 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.